Buying Guide — 2026-05-19
Every year, a handful of peptides dominate research catalogs — the ones with the strongest data, the clearest mechanisms, and the most reproducible endpoints. 2026's top sellers reflect a maturation of the peptide-research landscape: GP-class metabolic agents have moved into Phase 3, the mitochondrial-derived peptide story has consolidated, and the orthopedic recovery stack has become standardized. This article is a research-grounded breakdown of the top peptides researchers are buying, what each is best at, and how they fit together.
Researcher special: code WELCOME at checkout unlocks 35% off every peptide in this article and every research stack. Every vial ships with a batch-matched COA at 99%+ HPLC purity and US-based handling.
Reta (LY3437943) is the most-studied triple receptor agonist (GP-1 + GIP + glucagon) in 2026 research. It's the peptide with the largest single-compound body-weight reduction signal ever reported — ~24% mean reduction at 48 weeks in the Phase 2 trial (Jastreboff et al., NEJM 2023).
Best for: Body-composition, metabolic, MASLD, and cardiometabolic research models.
Why it sells: The magnitude of the signal. No other single peptide produces a comparable body-weight or liver-fat change. The Phase 3 TRIUMPH program is generating rolling readouts that continue to support the Phase 2 data.
Key reads: - What is reta — mechanism overview - Reta benefits and side effects - Reta results timeline — month-by-month expectations - Reta beginner dosing protocol
Typical research protocol: Weekly subcutaneous, 12–16 week titration, 24–48 week endpoint horizon.
Tesamorelin is the only peptide with a specific FDA indication for visceral adipose tissue (VAT) reduction. The visceral-fat specificity comes from GHRH-driven preferential lipolysis of metabolically active fat depots — VAT is reduced ~15–18% over 26 weeks at the standard 2 mg/day SC dose without significant total-weight change.
Best for: VAT-specific research, MASLD/liver-fat studies, body-recomposition models where fat distribution (not just total fat) is the endpoint.
Why it sells: It's the most VAT-selective peptide on the market. The Stanley et al. (Lancet HIV, 2019) MASLD data extended its use case beyond the original HIV-lipodystrophy indication, and researchers running body-recomposition protocols increasingly stack it with metabolic peptides.
Key reads: - Tesamorelin research overview - Tesamorelin for visceral fat — the deep-dive - Tesamorelin dosing and cycling
Typical research protocol: 2 mg SC daily, evening administration, 12–26 week minimum cycle.
MOTS-c is a 16-amino-acid mitochondrially-encoded peptide discovered by Lee et al. (Cell Metabolism, 2015). It activates AMPK in skeletal muscle and produces metabolic improvements consistent with what aerobic exercise produces in muscle — improved insulin sensitivity, increased fatty acid oxidation, mitochondrial biogenesis.
Best for: Insulin sensitivity research, metabolic flexibility models, aging/longevity research, complement to appetite-suppressing peptides in body-composition stacks.
Why it sells: Two reasons. First, the mechanism is mechanistically distinct from the GP-class — substrate utilization rather than appetite suppression — so it stacks cleanly. Second, the "exercise mimetic" framing is intuitive and the Reynolds et al. (2021, Nature Communications) aging-reversal data is compelling.
Key reads: - MOTS-c mitochondrial peptide - MOTS-c for fat loss and metabolic research — the deep dive - Shred stack: Reta + Tesa + MOTS-c
Typical research protocol: 5–10 mg SC 2–3× weekly, 4–8 week cycles.
The Wolverine Stack is a 1:1 blend of BPC-157 and TB-500 (Thymosin Beta-4) and has become the de-facto standard combination for tendon, ligament, and connective-tissue repair research. The two peptides act on largely non-overlapping repair pathways — BPC-157 drives localized matrix repair and angiogenesis; TB-500 drives systemic cell migration and inflammation modulation.
Best for: Tendinopathy, ligament repair, joint research, chronic soft-tissue research models, recovery support during heavy training research.
Why it sells: Recovery research is one of the largest applied use-cases for peptides, and the BPC + TB combination is the most-cited combination in the orthopedic literature. The Chang et al. (2011) Achilles tendon work is the anchor study, and subsequent rotator-cuff and chondral-defect models have extended the use case.
Key reads: - BPC-157 research guide - TB-500 research overview - Wolverine Stack explained - Wolverine Stack dosing guide - Wolverine Stack for joint and tendon research — orthopedic deep-dive
Typical research protocol: 250/250 mcg SC 2× weekly, 6–8 week cycles, site-selected close to the target tissue when BPC localization matters.
IGF-1 LR3 is a long-acting, high-bioavailability IGF-1 analog (Arg3 substitution + N-terminal extension reducing IGFBP binding). It drives the canonical mTOR-mediated anabolic pathway in skeletal muscle and activates satellite cell proliferation.
Best for: Muscle-anabolism research, satellite-cell biology, recovery during heavy training research. The "hyperplasia" claim is partially supported under specific overload conditions; the well-supported effect is hypertrophy.
Why it sells: It's the most direct anabolic peptide on the market. Researchers running muscle-specific endpoints (fiber size, contractile force, satellite-cell pool expansion) reach for IGF-1 LR3 because the signal is reliable and the mechanism is well-characterized.
Key reads: - IGF-1 LR3 research overview - IGF-1 LR3 muscle hyperplasia research — the hyperplasia question, honestly - IGF-1 LR3 dosing protocol - IGF-1 LR3 stacking with GH peptides
Typical research protocol: 20–60 mcg SC daily, post-training, 4–6 week cycles with 4–6 week off-periods.
CJC-1295 (no DAC) and Ipamorelin in combination produce a GH pulse 3–5× larger than either alone. The pulsatile pattern is preserved (because both peptides have short half-lives), and pre-sleep dosing aligns the exogenously-driven pulse with the natural overnight slow-wave-sleep pulse.
Best for: Sleep architecture research, overnight recovery research, body-recomposition research, complement to direct anabolic agents.
Why it sells: It's the most physiologically clean way to amplify the GH axis. Ipamorelin's selectivity (no cortisol, prolactin, or ACTH cross-reactivity) makes it the standard GH secretagogue for protocols where side-effect cleanliness matters.
Key reads: - CJC-1295 research overview - Ipamorelin research profile - CJC/Ipamorelin dosing guide - CJC/Ipamorelin for sleep and recovery — the sleep deep-dive
Typical research protocol: 100 mcg CJC + 100 mcg Ipa SC pre-sleep, fasted, 5–7 days/week, 8–12 week cycles.
A few peptides that consistently sit just below the top sellers but anchor specific research lines:
The top sellers map naturally onto distinct research axes, which is why they sell as stacks more than as single vials.
The single most important factor in research-peptide sourcing is batch-matched COA documentation. Every top peptide on this list is being studied at endpoints (body weight, VAT, IGF-1, biomechanical strength) that depend on consistent batch potency. A 5% purity variance between lots can move the effect signal more than the dose change you're testing.
What a usable COA shows: - HPLC purity ≥98%, ideally ≥99% - Mass spectrometry confirmation matching the theoretical mass - Batch/lot number that matches the vial you received - Recent test date (within months of your purchase)
For deeper detail on COA evaluation, see what is a peptide COA and understanding peptide purity. For supplier evaluation more broadly, see where to buy research peptides.
For researchers running the top-seller stack:
| Product | Use |
| Reta 20mg | Metabolic / fat-loss research |
| Tesamorelin 10mg | VAT-specific research |
| MOTS-c 10mg | Insulin sensitivity / metabolic flexibility |
| Wolverine 20mg | Connective-tissue repair research |
| IGF-1 LR3 | Direct muscle-anabolism research |
| CJC/Ipa blend | Sleep / overnight GH pulse research |
| Bacteriostatic water 10mL | Multi-vial reconstitution |
| U-100 insulin syringes | Sub-mg dose accuracy |
Code WELCOME at checkout unlocks 35% off every peptide in this article, every Stack, the Metabolic Stack, the Shredder family, the Wolverine and Wolverine Repair Stacks, and bacteriostatic water. Every vial ships with a batch-matched COA showing 99%+ HPLC purity, US-based handling, and the sequence-verified identity required for endpoint-driven research over 8–48 week protocols.
Disclaimer: All information presented in this article is for educational and informational purposes only. Platinum Biolabs does not promote or endorse the use of peptides for human consumption. All products sold by Platinum Biolabs are intended strictly for laboratory and research use only. Consult a qualified healthcare professional before making any health-related decisions.